GRIFOLS/ ES0171996087 /
10/18/2024 5:35:28 PM | Chg. +0.1460 | Volume | Bid6:01:26 PM | Ask5:45:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
9.9920EUR | +1.48% | 1.53 mill. Turnover: 15.15 mill. |
9.7640Bid Size: 500 | 9.9800Ask Size: 200 | 8.45 bill.EUR | - | 111.02 |
GlobeNewswire
7/31
GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HB...
GlobeNewswire
7/29
Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strength...
GlobeNewswire
7/1
Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years
Newsfile Corp
6/27
GRFS SHAREHOLDER ALERT: Johnson Fistel Announces Class Action Investigation of Grifols, S.A. for Pot...
GlobeNewswire
6/18
Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group
GlobeNewswire
6/17
Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immu...
GlobeNewswire
5/20
GigaGen Doses First Patient in Phase 1 Trial of Anti-CTLA-4 Oncology Drug Candidate GIGA-564 in Adva...
GlobeNewswire
4/18
Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at ...
GlobeNewswire
4/4
Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Scree...
GlobeNewswire
3/31
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire
3/29
Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire
3/25
Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire
3/23
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire
3/22
Johnson Fistel, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investig...
GlobeNewswire
3/20
Grifols S.A. (GRFS – ADR ADR Class B) Shares Decline Again After Gotham City Research Issues Another...
GlobeNewswire
3/15
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire
3/1
GRFS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Grifols S.A. (NASDAQ: GRFS) ...
GlobeNewswire
2/12
Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman
GlobeNewswire
2/11
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Grifols S.A. - G...
GlobeNewswire
2/8
Analyst Downgrades Grifols S.A. (GRFS) After Recent Short Seller Report – Hagens Berman